AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Search Results for: "National Institutes of Health"

National HIV/AIDS and Aging Awareness Day: A Perspective from the National Institutes of Health

blog.aids.gov

Co-authored by Scott Proestel, M.D., Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH

On September 18, 2011, we mark the fourth observance of National HIV/AIDS and Aging Awareness Day. The remarkable success of antiretroviral therapies in prolonging the lives of HIV-infected individuals who have access to and can tolerate these drugs has

The Path to a Cure for Hepatitis C in People with HIV

NIH logo

Hepatitis C can be a chronic condition that leads to liver failure, and treatments often haven’t worked for patients who are also co-infected with HIV. Thanks to research led by the National Institute of Allergy and Infectious Diseases and Gilead Sciences, new therapies are now available that can cure even complicated cases of hepatitis C…

Early Antiretroviral Therapy Prevents Non-Aids Outcomes in HIV-Infected People, NIH-Supported Study Finds

NIH logo

New Findings Illustrate Manifold Benefit of Therapy Starting antiretroviral therapy early not only prevents serious AIDS-related diseases, but also prevents the onset of cancer, cardiovascular disease, and other non-AIDS-related diseases in HIV-infected people, according to a new analysis of data from the Strategic Timing of AntiRetroviral Treatment (START) study, the first large-scale randomized clinical trial to…

HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus

NIH logo

NIH-Funded Trial Proves Suppressive Antiretroviral Therapy for HIV-infected People Effective in Protecting Uninfected Partners ​Antiretroviral treatment that consistently suppresses HIV is highly effective at preventing sexual transmission of the virus in heterosexual couples where one person is HIV-infected and the other is not, investigators report today at the 8th International AIDS Society Conference on HIV…

International Study Demonstrates Benefits of Early HIV Treatment

Dr. Anthony Fauci

The question of when to initiate antiretroviral therapy (ART) during the course of HIV infection has been debated for years, yet a conclusive answer has remained elusive. For HIV-infected individuals the primary question was whether to start ART early, risking possible cumulative drug toxicities, potential viral resistance, and difficulties with long-term adherence, or to defer…

Starting antiretroviral treatment early improves outcomes for HIV-infected individuals

nih logo

For Immediate Release: Wednesday, May 27, 2015 NIH-funded trial results likely will impact global treatment guidelines A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count—a key measure of immune…

HOPE Act to facilitate organ recovery from HIV-positive donors

HRSA logo

In a notice published in the Federal Register on May 8, 2015, the U.S. Department of Health and Human Services announced it will amend the OPTN Final Rule (42 CFR Part 121) to allow the recovery of transplantable organs from HIV-positive donors. This is a milestone in support of the federal HIV Organ Policy Equity…

New! NIH Clinical Trials Media Player Now Available

NIH media player

Clinical Trials Clinical trials play an immensely important role in finding medical advancements and developing treatments for many diseases and conditions, including HIV. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving quality…